What is the main business of DR Marek Cegielski?

The main business activity of DR Marek Cegielski focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 9, 2011.

Where is the headquarters located?

The headquarters is located at: Teofila Lenartowicza 6, 51-140 Wrocław.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

What revenue was generated?

In 2023, the company generated total revenue of $8,172, representing a decrease of 62.6% compared to 2022.

Yes, the company recorded a net profit of $6,279 in 2023, meaning the company decreased its profit by 35.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $793 in 2023, representing 67% of all operating expenses.

DR Marek Cegielskisp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2011-02-09

Share capital

5,000.00 PLN

Registered address

Teofila Lenartowicza 6, 51-140 Wrocław, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed.

2024not filed
202306/06/2024
202225/05/2023
202123/06/2022
202002/07/2021
201916/06/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 8.17kMedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD 6.28kMedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 1.19kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 11.29kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Zofia Cegielska – President of the Management Board

Manner of representation

The following are authorized to submit declarations of will on behalf of the company: A) in the case of a one-person management board – the President of the Management Board independently; B) in the case of a multi-member management board – two members of the management board jointly, or one member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Zofia Cegielskaage 82	50	$675.31	50%
Marek Andrzej Cegielskiage 74	50	$675.31	50%

Marek Andrzej Cegielski and Zofia Cegielska hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

No beneficial owners recorded for the company DR Marek Cegielski.

Bank accounts

Was a VAT taxpayer from 2011-03-01 to 2026-03-10.

Reason for removal: Art. 96 ust. 9 pkt 4 (taxpayer or their representative fails to appear on summons of tax authorities)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Oct 7, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Wrocławia

Competitors

Name	Revenue	Website
Vitrotest Europesp. z o.o.	$233,350.77	vitrotest.pl
VASA Therapeuticssp. z o.o.	$216,535.01	vasatherapeutics.com
MultiqureS.A.	$149,394.35	purebiologics.com
GenomtecS.A.	$54,746.36	genomtec.com
Vitagenumsp. z o.o.	$9,376.94	vitagenum.pl
4cell TherapiesS.A.	$9,123.06	4celltherapies.com
Meritrosp. z o.o.	$7,890.74	meritro.com
Oncotherics PolandS.A.	$7,565.33	oncotherics.com
Centrum Transferu Technologii Meditransfer Iitdsp. z o.o.	$228.56	iitd.pan.wroc.pl
Olenasp. z o.o.	–	imsolutions.pl